Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Investigating oxalate production in patients with calcium oxalate kidney stones

Official title: Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Formers

Run by University of Alabama at Birmingham · NCT06989320 · Data updated 2026-11-12

This study is testing if people with calcium oxalate kidney stones produce more oxalate in their bodies than healthy individuals by following a special diet and taking certain supplements.

More Nephrolithiasis trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment80 (estimated)
SponsorUniversity of Alabama at Birmingham
Academic / other
Locations2 sites (Birmingham, Alabama and 1 other locations)
StatusRecruiting
StartedMay 27, 2025
Main results expectedDecember 31, 2030
Study endsDecember 31, 2031
Registry record updatedAugust 27, 2026
Trial IDNCT06989320 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18-80 with a history of calcium oxalate kidney stones.

Probably not a fit

Patients with chronic kidney disease, primary hyperoxaluria, or other significant renal or metabolic disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to determine if individuals with idiopathic calcium oxalate kidney stones produce more oxalate in their bodies compared to healthy individuals. Participants will follow a low-oxalate diet for five days and undergo tests involving the ingestion of glycolate and vitamin C to measure oxalate production. The study will recruit 80 subjects, including 40 kidney stone formers and 40 healthy controls, matched by age and gender. Urine, blood, and stool samples will be collected to analyze the effects of diet and oral dosing on oxalate synthesis.

Why it matters

Potential benefit: If successful, this study could lead to better understanding and management of calcium oxalate kidney stones, potentially reducing recurrence rates.

How similar studies have gone: While this approach is novel in its specific focus on endogenous oxalate synthesis, similar studies have explored dietary impacts on kidney stone formation with varying degrees of success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age 18-80 yrs
* Body Mass Index \> 18.5 kg/m2
* Normal fasting serum electrolytes on comprehensive metabolic profile
* Willing to ingest fixed diets
* Willing to stop supplements (vitamins including vitamin C, calcium (citrate or carbonate) and other minerals, herbal supplements, nutritional aids, probiotics) for 2 weeks before start and during study.
* For stone formers: first time or recurrent Calcium Oxalate stone former. Composition of most recent stone ≥ 50% calcium oxalate if available, uric acid component \<20%

Exclusion Criteria:

* Chronic Kidney Disease stage 4-5
* Primary hyperoxaluria, Enteric (secondary) hyperoxaluria
* Liver, bowel, endocrine or renal diseases (other than idiopathic Calcium Oxalate kidney stones) or any other condition that may influence the absorption, transport or urinary excretion of ions, which will compromise the interpretation of results, including: Cystic fibrosis, Celiac disease, Cystinuria, Uric acid stone former, Nephrotic syndrome, Sarcoidosis, Renal tubular acidosis, Primary hyperparathyroidism, Neurogenic bladder, Urinary diversion, Chronic diarrhea, Bariatric surgery, Inflammatory bowel disease
* Pregnancy or breast-feeding
* Incompatible dietary requirements with the study, food allergies or intolerance to any of the foods in study menus
* Active malignancy or treatment for malignancy within 12 months prior to screening
* Utilization of immunosuppressive medication
* Uncontrolled hypertension or diabetes
* Diabetes type 1

Where it's running

  • United States, Alabama University of Alabama at Birmingham
    Birmingham, Alabama, United States
    Recruiting
  • University of Texas South Western Medical Center
    Dallas, Texas, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Sonia Fargue, PhD — University of Alabama at Birmingham
  • Study coordinator: Sonia Fargue, PhD
  • Email: sfargue@uabmc.edu
  • Phone: 205-975-6932

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.